| exhibit anticonvulsant … | 0.55 |
| appear in breast milk | 0.49 |
| cross placental barrier | 0.48 |
| treat seizure | 0.48 |
| produce excitement | 0.45 |
| bind to the gabaa recep… | 0.39 |
| potentiate the effect o… | 0.36 |
| induce hepatic microsom… | 0.33 |
| decrease anticoagulant … | 0.33 |
| increase the duration | 0.30 |
| More » |
| drowsiness | 0.47 |
| death | 0.28 |
| restlessness | 0.16 |
| breathing problems | 0.16 |
| unconsciousness | 0.16 |
| fda-approved indication | 0.27 |
| physical | 0.25 |
| psychological | 0.25 |
| suicidal tendencies | 0.25 |
| a history of drug abuse | 0.25 |
| high potential | 0.16 |
| central nervous system … | 0.63 |
| drug | 0.53 |
| sedative | 0.48 |
| controlled substances | 0.41 |
| depressant | 0.40 |
| used to treat anxiety | 0.68 |
| replaced by benzodiazep… | 0.58 |
| used to treat insomnia | 0.57 |
| prescribed | 0.56 |
| added | 0.53 |
| used as anesthetic | 0.52 |
| administered | 0.46 |
| abused | 0.45 |
| used as sedative hypnot… | 0.41 |
| used to treat epilepsy | 0.41 |
| More » |
| mild sedation | 0.49 |